Immunogenicity: No Antibody Formation A critical safety consideration for any peptide therapy is immunogenicity, the potential to trigger immune system responses that could lead to allergic reactions, reduced efficacy through antibody neutralization, or autoimmune complications
Based on ingesting 8 g of CM with a 1.1:1 ratio, individuals are only ingesting 4.2 g instead of 5.3 g (the latter based on a 2:1 ratio)
Circulation 101 , 948954 (2000)
Because many endometriosis patients want both reliable contraception and symptom control, less user-dependent methods often reduce stressespecially if GLP1 side effects are significant
While it is generally considered safe during breastfeeding, especially in low concentrations, caution is still necessary
In preclinical and exploratory human research, GHRP-2 has been studied for its ability to increase circulating growth hormone and influence downstream IGF-1 signaling